Literature DB >> 20150171

The PFO anatomy evaluation as possible tool to stratify the associated risks and the benefits arising from the closure.

Giovanni Fazio1, Giovanni Ferro, Patrizia Carità, Monica Lunetta, Alessandro Gullotti, Renato Trapani, Adele Fabbiano, Giuseppina Novo, Salvatore Novo.   

Abstract

AIMS: According to the current guidelines, the patent foramen ovale (PFO) is still considered a qualitative factor and, as a consequence, its closure is recommended just on the basis of its 'presence'. METHODS AND
RESULTS: In the year 2008, we evaluated 25 patients (mean age 62.7) with acute cerebrovascular event and 92 patients (mean age 27.3) suffering from migraine with aura. No PFO was reported in 79 patients. A venous-to-arterial circulation shunt had been shown in 38 patients (29 subjects with migraine and 9 subjects with prior stroke). According to the number of microbubbles arrived during the Valsava manoeuvre, we found: 25 small PFO, 6 moderate PFO, and 6 severe PFO. In the baseline population with migraine (n = 92), 32% (n = 29) had a PFO. A 'large' foramen was reported in approximately 9% of the migraine subjects. In the population with prior stroke (n=25), 9 patients (36%) had a PFO. A 'large' foramen was reported in 45% of the patients with ischaemic stroke. We found embryonic recesses in 13% (n = 4) of the patients with migraine and PFO (n=29) vs. 66% (n=6) of the patients with ischaemic stroke and PFO (P= 0.01).
CONCLUSION: It is possible to suppose that not all PFO have the same prognostic value. The evaluation of two anatomical characteristics can allow to identify those foramina at higher risk and, as a consequence, the patients who could have a major benefit from the closure.

Entities:  

Mesh:

Year:  2010        PMID: 20150171     DOI: 10.1093/ejechocard/jeq003

Source DB:  PubMed          Journal:  Eur J Echocardiogr        ISSN: 1532-2114


  4 in total

Review 1.  Contemporary echocardiographic guiding tools for device closure of interatrial communications.

Authors:  Thomas Bartel; Silvana Müller
Journal:  Cardiovasc Diagn Ther       Date:  2013-03

Review 2.  Comorbidity of Migraine.

Authors:  Şebnem Biçakci
Journal:  Noro Psikiyatr Ars       Date:  2013-08-01       Impact factor: 1.339

Review 3.  The brain's heart - therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease.

Authors:  Mingming Ning; Eng H Lo; Pei-Chen Ning; Su-Yu Xu; David McMullin; Zareh Demirjian; Ignacio Inglessis; G William Dec; Igor Palacios; Ferdinando S Buonanno
Journal:  Pharmacol Ther       Date:  2013-03-23       Impact factor: 12.310

4.  Transesophageal Contrast Echocardiography is Not Always the Gold Standard Method in the Identification of a Patent Foramen Ovale: A Clinical Case.

Authors:  Monica Lunetta; Francesco Costa; Marcello La Gattuta; Salvatore Novo
Journal:  J Cardiovasc Echogr       Date:  2015 Jul-Sep
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.